GPC3 and hepatocellular carcinoma: During HCV-mediated liver disease and HCC, the virus, and in particular its membrane glycoprotein E2, which binds CD81, was shown to mimic GPC3 in infected hepatocytes, thereby interfering with the GPC3/CD81 binding [69].